These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31129500)

  • 1. Synthesis, biological evaluation and molecular docking studies of novel 3,5-disubstituted 2,4-thiazolidinediones derivatives.
    Ranjan Srivastava A; Bhatia R; Chawla P
    Bioorg Chem; 2019 Aug; 89():102993. PubMed ID: 31129500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-γ modulators.
    Naim MJ; Alam O; Alam MJ; Shaquiquzzaman M; Alam MM; Naidu VGM
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700223. PubMed ID: 29400412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization, biological evaluation and docking of coumarin coupled thiazolidinedione derivatives and its bioisosteres as PPARγ agonists.
    Shukla S; Kumar P; Das N; Moorthy NS; Shrivastava SK; Trivedi P; Srivastava RS
    Med Chem; 2012 Sep; 8(5):834-45. PubMed ID: 22741802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, molecular docking and anti-diabetic evaluation of 2,4-thiazolidinedione based amide derivatives.
    Naim MJ; Alam MJ; Nawaz F; Naidu VGM; Aaghaz S; Sahu M; Siddiqui N; Alam O
    Bioorg Chem; 2017 Aug; 73():24-36. PubMed ID: 28582649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological evaluation and molecular modeling studies of arylidene-thiazolidinediones with potential hypoglycemic and hypolipidemic activities.
    da Costa Leite LF; Veras Mourão RH; de Lima Mdo C; Galdino SL; Hernandes MZ; de Assis Rocha Neves F; Vidal S; Barbe J; da Rocha Pitta I
    Eur J Med Chem; 2007 Oct; 42(10):1263-71. PubMed ID: 17448573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis, and Biological Evaluation of Thiazolidine-2,4-dione Conjugates as PPAR-γ Agonists.
    Nazreen S; Alam MS; Hamid H; Shahar Yar M; Dhulap A; Alam P; Pasha MA; Bano S; Alam MM; Haider S; Kharbanda C; Ali Y; Pillai K
    Arch Pharm (Weinheim); 2015 Jun; 348(6):421-32. PubMed ID: 25900064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of novel 5-(imidazolyl-methyl) thiazolidinediones as antidiabetic agents.
    Shakour N; Sahebkar A; Karimi G; Paseban M; Tasbandi A; Mosaffa F; Tayarani-Najaran Z; Ghodsi R; Hadizadeh F
    Bioorg Chem; 2021 Oct; 115():105162. PubMed ID: 34314919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazolidine-2,4-diones derivatives as PPAR-γ agonists: synthesis, molecular docking, in vitro and in vivo antidiabetic activity with hepatotoxicity risk evaluation and effect on PPAR-γ gene expression.
    Nazreen S; Alam MS; Hamid H; Yar MS; Dhulap A; Alam P; Pasha MA; Bano S; Alam MM; Haider S; Kharbanda C; Ali Y; Pillai KK
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3034-42. PubMed ID: 24890090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of thiazolidine-2,4-dione-pyrazole conjugates as antidiabetic, anti-inflammatory and antioxidant agents.
    Bansal G; Singh S; Monga V; Thanikachalam PV; Chawla P
    Bioorg Chem; 2019 Nov; 92():103271. PubMed ID: 31536952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization and biological evaluation of some novel 2,4-thiazolidinediones as potential cytotoxic, antimicrobial and antihyperglycemic agents.
    Avupati VR; Yejella RP; Akula A; Guntuku GS; Doddi BR; Vutla VR; Anagani SR; Adimulam LS; Vyricharla AK
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6442-50. PubMed ID: 22981328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and molecular docking of thiazolidinedione based benzene sulphonamide derivatives containing pyrazole core as potential anti-diabetic agents.
    Naim MJ; Alam O; Alam MJ; Hassan MQ; Siddiqui N; Naidu VGM; Alam MI
    Bioorg Chem; 2018 Feb; 76():98-112. PubMed ID: 29169079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, in-vitro α-glucosidase inhibition, antioxidant, in-vivo antidiabetic and molecular docking studies of pyrrolidine-2,5-dione and thiazolidine-2,4-dione derivatives.
    Hussain F; Khan Z; Jan MS; Ahmad S; Ahmad A; Rashid U; Ullah F; Ayaz M; Sadiq A
    Bioorg Chem; 2019 Oct; 91():103128. PubMed ID: 31369977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, ADME, docking studies and in vivo anti-hyperglycaemic potential estimation of novel Schiff base derivatives from octadec-9-enoic acid.
    Kapoor G; Pathak DP; Bhutani R; Husain A; Jain S; Iqbal MA
    Bioorg Chem; 2019 Mar; 84():478-492. PubMed ID: 30579158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis and Molecular Docking Studies of Novel Thiadiazole Analogues with Potential Antimicrobial and Antiinflammatory Activities.
    Mehta DK; Taya P; Das R; Dua K
    Antiinflamm Antiallergy Agents Med Chem; 2019; 18(2):91-109. PubMed ID: 30848217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A convenient approach to synthesize substituted 5-Arylidene-3-m-tolyl thiazolidine-2, 4-diones by using morpholine as a catalyst and its theoretical study.
    Jahan K; Khan KR; Akhter K; Romman UKR; Halim E
    PLoS One; 2021; 16(3):e0247619. PubMed ID: 33661961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiazolidinedione Derivatives: In Silico, In Vitro, In Vivo, Antioxidant and Anti-Diabetic Evaluation.
    Sameeh MY; Khowdiary MM; Nassar HS; Abdelall MM; Amer HH; Hamed A; Elhenawy AA
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4(3H)-one derivatives as potential PPARγ and SUR agonists.
    Ibrahim MK; Eissa IH; Alesawy MS; Metwaly AM; Radwan MM; ElSohly MA
    Bioorg Med Chem; 2017 Sep; 25(17):4723-4744. PubMed ID: 28720328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocatalytic one pot three component approach: Facile synthesis, characterization, molecular modelling and hypoglycemic studies of new thiazolidinedione festooned quinoline analogues catalyzed by alkaline protease from Aspergillus niger.
    Angajala G; Aruna V; Pavan P; Guruprasad Reddy P
    Bioorg Chem; 2022 Feb; 119():105533. PubMed ID: 34902647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2,4-diones bis-heterocycles as PPAR-γ agonists.
    Nazreen S; Alam MS; Hamid H; Yar MS; Shafi S; Dhulap A; Alam P; Pasha MA; Bano S; Alam MM; Haider S; Ali Y; Kharbanda C; Pillai KK
    Eur J Med Chem; 2014 Nov; 87():175-85. PubMed ID: 25255433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of sulpha drug based hydroxytriazene derivatives: Anti-diabetic, antioxidant, anti-inflammatory activity and their molecular docking studies.
    Sharma P; Dayma V; Dwivedi A; Baroliya PK; Tripathi IP; Vanangamudi M; Chauhan RS; Goswami AK
    Bioorg Chem; 2020 Mar; 96():103642. PubMed ID: 32062065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.